Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Evaluation of the effectiveness of caspofungin against febrile neutropenia and the factors related to the alteration in its plasma concentration.

Shibata Y, Miyahara Y, Sadaka Y, Yasue M, Fujimura M, Soda M, Yamamoto M, Kato H, Suzuki A, Tsukamoto K, Hara T, Tsurumi H, Kitaichi K.

J Infect Chemother. 2019 Apr 29. pii: S1341-321X(19)30105-9. doi: 10.1016/j.jiac.2019.04.011. [Epub ahead of print]

PMID:
31047782
2.

Determination of lamotrigine in human plasma using liquid chromatography-tandem mass spectrometry.

Itabashi S, Bito R, Nishina M, Fukumoto M, Soda M, Doi M, Usui S, Kitaichi K.

Neuropsychopharmacol Rep. 2019 Mar;39(1):48-55. doi: 10.1002/npr2.12045. Epub 2019 Jan 2.

3.

A simplified chart for determining the initial loading dose of teicoplanin in critically ill patients.

Yoshida S, Suzuki A, Ohmori T, Niwa T, Okada H, Suzuki K, Kobayashi R, Doi T, Kitaichi K, Matsuura K, Murakami N, Ogura S, Itoh Y.

Pharmazie. 2017 Jan 10;72(1):53-57. doi: 10.1691/ph.2017.6811.

PMID:
29441898
4.

Evaluation of the Microbiological Efficacy of a Single 2-Gram Dose of Extended-Release Azithromycin by Population Pharmacokinetics and Simulation in Japanese Patients with Gonococcal Urethritis.

Soda M, Ito S, Matsumaru N, Nakamura S, Nagase I, Takahashi H, Ohno Y, Yasuda M, Yamamoto M, Tsukamoto K, Itoh Y, Deguchi T, Kitaichi K.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01409-17. doi: 10.1128/AAC.01409-17. Print 2018 Jan.

5.

Nitric Oxide Plasma Level as a Barometer of Endothelial Dysfunction in Factory Workers.

Miyata S, Noda A, Hara Y, Ueyama J, Kitaichi K, Kondo T, Koike Y.

Exp Clin Endocrinol Diabetes. 2017 Nov;125(10):684-689. doi: 10.1055/s-0043-110054. Epub 2017 Jul 27.

PMID:
28750431
6.

Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms.

Soda M, Fujitani M, Michiuchi R, Shibayama A, Kanamori K, Yoshikuni S, Ohno Y, Tsuchiya T, Suzuki A, Horie K, Deguchi T, Itoh Y, Kitaichi K.

Transplant Proc. 2017 Jul - Aug;49(6):1492-1498. doi: 10.1016/j.transproceed.2017.03.093.

PMID:
28736028
7.

Analytical differentiation of quinolinyl- and isoquinolinyl-substituted 1-(5-fluoropentyl)-1H-indole-3-carboxylates: 5F-PB-22 and its ten isomers.

Kohyama E, Chikumoto T, Tada H, Kitaichi K, Ito T.

Forensic Toxicol. 2017;35(1):56-65. doi: 10.1007/s11419-016-0334-9. Epub 2016 Aug 12.

8.

Differentiation of the Isomers of N-Alkylated Cathinones by GC-EI-MS-MS and LC-PDA.

Kohyama E, Chikumoto T, Tada H, Kitaichi K, Horiuchi T, Ito T.

Anal Sci. 2016;32(8):831-7. doi: 10.2116/analsci.32.831.

9.

Gomafu lncRNA knockout mice exhibit mild hyperactivity with enhanced responsiveness to the psychostimulant methamphetamine.

Ip JY, Sone M, Nashiki C, Pan Q, Kitaichi K, Yanaka K, Abe T, Takao K, Miyakawa T, Blencowe BJ, Nakagawa S.

Sci Rep. 2016 Jun 2;6:27204. doi: 10.1038/srep27204.

10.

Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.

Nawata Y, Kitaichi K, Yamamoto T.

Drug Alcohol Depend. 2016 Mar 1;160:76-81. doi: 10.1016/j.drugalcdep.2015.12.016. Epub 2015 Dec 30.

PMID:
26796595
11.

Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer.

Hayashi H, Kita Y, Iihara H, Yanase K, Ohno Y, Hirose C, Yamada M, Todoroki K, Kitaichi K, Minatoguchi S, Itoh Y, Sugiyama T.

Biomed Chromatogr. 2016 Jul;30(7):1150-1154. doi: 10.1002/bmc.3642. Epub 2015 Dec 1.

PMID:
26525154
12.

Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.

Hayashi H, Kobayashi R, Suzuki A, Ishihara M, Nakamura N, Kitagawa J, Kanemura N, Kasahara S, Kitaichi K, Hara T, Tsurumi H, Moriwaki H, Itoh Y.

Anticancer Res. 2014 Dec;34(12):7271-7.

PMID:
25503160
13.

Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes.

Fujioka R, Nii T, Iwaki A, Shibata A, Ito I, Kitaichi K, Nomura M, Hattori S, Takao K, Miyakawa T, Fukumaki Y.

Mol Brain. 2014 Apr 23;7:31. doi: 10.1186/1756-6606-7-31.

14.

[Evaluation of the efforts of pharmaceutical care services before medical examination at an outpatient cancer chemotherapy clinic].

Yoshimi C, Yamada M, Fujii H, Nishigaki M, Iihara H, Kitaichi K, Takahashi M, Kurahashi S, Takahashi T, Yoshida K, Itoh Y.

Gan To Kagaku Ryoho. 2013 Mar;40(3):349-54. Japanese.

PMID:
23507597
15.

Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant.

Aoki S, Iihara H, Nishigaki M, Imanishi Y, Yamauchi K, Ishihara M, Kitaichi K, Itoh Y.

Mol Clin Oncol. 2013 Jan;1(1):41-46. Epub 2012 Aug 27.

16.

Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital.

Niwa T, Shinoda Y, Suzuki A, Ohmori T, Yasuda M, Ohta H, Fukao A, Kitaichi K, Matsuura K, Sugiyama T, Murakami N, Itoh Y.

Int J Clin Pract. 2012 Oct;66(10):999-1008. doi: 10.1111/j.1742-1241.2012.02999.x. Epub 2012 Jul 31.

17.

The evaluation of risk factors associated with adverse drug reactions by metformin in type 2 diabetes mellitus.

Okayasu S, Kitaichi K, Hori A, Suwa T, Horikawa Y, Yamamoto M, Takeda J, Itoh Y.

Biol Pharm Bull. 2012;35(6):933-7.

18.

Diacylglycerol kinase β knockout mice exhibit attention-deficit behavior and an abnormal response on methylphenidate-induced hyperactivity.

Ishisaka M, Kakefuda K, Oyagi A, Ono Y, Tsuruma K, Shimazawa M, Kitaichi K, Hara H.

PLoS One. 2012;7(5):e37058. doi: 10.1371/journal.pone.0037058. Epub 2012 May 10.

19.

Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock.

Nawata Y, Kitaichi K, Yamamoto T.

Pharmacol Biochem Behav. 2012 Apr;101(2):297-302. doi: 10.1016/j.pbb.2012.01.003. Epub 2012 Jan 12.

PMID:
22252103
20.

Development of fast dissolving oral film containing dexamethasone as an antiemetic medication: clinical usefulness.

Nishigaki M, Kawahara K, Nawa M, Futamura M, Nishimura M, Matsuura K, Kitaichi K, Kawaguchi Y, Tsukioka T, Yoshida K, Itoh Y.

Int J Pharm. 2012 Mar 15;424(1-2):12-7. doi: 10.1016/j.ijpharm.2011.12.057. Epub 2012 Jan 5.

PMID:
22240389
21.

A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.

Ishihara M, Ikesue H, Matsunaga H, Suemaru K, Kitaichi K, Suetsugu K, Oishi R, Sendo T, Araki H, Itoh Y; Japanese Study Group for the Relief of Opioid-induced Gastrointestinal Dysfunction.

Clin J Pain. 2012 Jun;28(5):373-81. doi: 10.1097/AJP.0b013e318237d626.

PMID:
22156893
22.

[Stimulative role of corticotropin-releasing factor in methamphetamine-seeking behavior induced by footshock].

Nawata Y, Kitaichi K, Yamamoto T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Apr;31(2):73-5. Japanese. No abstract available.

PMID:
21870363
23.

Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice.

Oyagi A, Oida Y, Kakefuda K, Shimazawa M, Shioda N, Moriguchi S, Kitaichi K, Nanba D, Yamaguchi K, Furuta Y, Fukunaga K, Higashiyama S, Hara H.

PLoS One. 2009 Oct 14;4(10):e7461. doi: 10.1371/journal.pone.0007461.

24.

A novel molecule 'shati' increases dopamine uptake via the induction of tumor necrosis factor-alpha in pheochromocytoma-12 cells.

Niwa M, Nitta A, Cen X, Kitaichi K, Ozaki N, Yamada K, Nabeshima T.

J Neurochem. 2008 Dec;107(6):1697-708. doi: 10.1111/j.1471-4159.2008.05738.x. Epub 2008 Nov 5.

25.

The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.

Tachikawa M, Kasai Y, Takahashi M, Fujinawa J, Kitaichi K, Terasaki T, Hosoya K.

J Neurochem. 2008 Oct;107(2):432-42. doi: 10.1111/j.1471-4159.2008.05641.x. Epub 2008 Aug 22.

26.

Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants.

Sakae N, Yamasaki N, Kitaichi K, Fukuda T, Yamada M, Yoshikawa H, Hiranita T, Tatsumi Y, Kira J, Yamamoto T, Miyakawa T, Nakayama KI.

Hum Mol Genet. 2008 Oct 15;17(20):3191-203. doi: 10.1093/hmg/ddn215. Epub 2008 Jul 22.

PMID:
18647754
27.

The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.

Nakayama H, Kitaichi K, Ito Y, Hashimoto K, Takagi K, Yokoi T, Takagi K, Ozaki N, Yamamoto T, Hasegawa T.

Brain Res. 2007 Dec 12;1184:260-9. Epub 2007 Oct 6.

PMID:
17988657
28.

Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome.

Noda A, Nakata S, Koike Y, Miyata S, Kitaichi K, Nishizawa T, Nagata K, Yasuma F, Murohara T, Yokota M.

Hypertens Res. 2007 Aug;30(8):669-76.

PMID:
17917313
29.
30.

Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.

Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N.

Alcohol Clin Exp Res. 2006 Oct;30(10):1644-9.

PMID:
17010131
31.

Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.

Zhang L, Kitaichi K, Fujimoto Y, Nakayama H, Shimizu E, Iyo M, Hashimoto K.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1381-93. Epub 2006 Jul 12.

PMID:
16839653
32.

Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.

Oida Y, Kitaichi K, Nakayama H, Ito Y, Fujimoto Y, Shimazawa M, Nagai H, Hara H.

Brain Res. 2006 Apr 12;1082(1):196-204. Epub 2006 Mar 3.

PMID:
16515773
33.

Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.

Miyazaki I, Asanuma M, Diaz-Corrales FJ, Fukuda M, Kitaichi K, Miyoshi K, Ogawa N.

FASEB J. 2006 Mar;20(3):571-3. Epub 2006 Jan 10.

PMID:
16403784
34.

Effect of Shiga-like toxin II from Escherichia coli O157:H7 on intestinal clearance of norfloxacin in rats.

Nakayama H, Kitaichi K, Kanazawa H, Ando M, Fujimoto Y, Takagi K, Takagi K, Hasegawa T.

Life Sci. 2006 Mar 20;78(17):1967-74. Epub 2005 Nov 8.

PMID:
16280134
35.

Effects of single and repeated administration of methamphetamine or morphine on neuroglycan C gene expression in the rat brain.

Ishikawa K, Nitta A, Mizoguchi H, Mohri A, Murai R, Miyamoto Y, Noda Y, Kitaichi K, Yamada K, Nabeshima T.

Int J Neuropsychopharmacol. 2006 Aug;9(4):407-15. Epub 2005 Sep 7.

PMID:
16146580
36.

Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice.

Kitaichi K, Fukuda M, Nakayama H, Aoyama N, Ito Y, Fujimoto Y, Takagi K, Takagi K, Hasegawa T.

Neurosci Lett. 2005 Jul 1-8;382(1-2):195-200. Epub 2005 Apr 2.

PMID:
15911148
37.

Altered brain penetration of diclofenac and mefenamic acid, but not acetaminophen, in Shiga-like toxin II-treated mice.

Fukuda M, Kitaichi K, Abe F, Fujimoto Y, Takagi K, Takagi K, Morishima T, Hasegawa T.

J Pharmacol Sci. 2005 Apr;97(4):525-32. Epub 2005 Apr 9.

38.

Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats.

Okuda T, Ito Y, Nakagawa N, Hishinuma T, Tsukamoto H, Iwabuchi K, Watanabe T, Kitaichi K, Goto J, Yanai K.

Eur J Pharmacol. 2004 Nov 28;505(1-3):135-44.

PMID:
15556146
39.

The altered disposition of methamphetamine in the model of methamphetamine-induced neurotoxicity.

Kitaichi K, Ito Y, Fukuda M, Aoyama N, Nakayama H, Takagi K, Hasegawa T.

Ann N Y Acad Sci. 2004 Oct;1025:248-56.

PMID:
15542724
40.

Serial alterations of beta-adrenergic signaling in dilated cardiomyopathic hamsters: possible role of myocardial oxidative stress.

Nishizawa T, Iwase M, Kanazawa H, Ichihara S, Ichihara G, Nagata K, Obata K, Kitaichi K, Yokoi T, Watanabe M, Tsunematsu T, Ishikawa Y, Murohara T, Yokota M.

Circ J. 2004 Nov;68(11):1051-60.

41.

Effect of pioglitazone on endotoxin-induced decreases in hepatic drug-metabolizing enzyme activity and expression of CYP3A2 and CYP2C11.

Ueyama J, Kitaichi K, Nadai M, Iwase M, Tomyo N, Kanazawa H, Suzuki R, Takagi K, Takagi K, Hasegawa T.

Eur J Pharmacol. 2004 Sep 13;498(1-3):257-65.

PMID:
15364003
42.

Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7.

Kitaichi K, Nakayama H, Ueyama J, Nadai M, Baba K, Takagi K, Takagi K, Ohta M, Hasegawa T.

Biochem Pharmacol. 2004 Apr 15;67(8):1427-35.

PMID:
15041460
43.

Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression.

Takeshita K, Fujimori T, Kurotaki Y, Honjo H, Tsujikawa H, Yasui K, Lee JK, Kamiya K, Kitaichi K, Yamamoto K, Ito M, Kondo T, Iino S, Inden Y, Hirai M, Murohara T, Kodama I, Nabeshima Y.

Circulation. 2004 Apr 13;109(14):1776-82. Epub 2004 Mar 22.

PMID:
15037532
44.

Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.

Nakajima A, Yamada K, Nagai T, Uchiyama T, Miyamoto Y, Mamiya T, He J, Nitta A, Mizuno M, Tran MH, Seto A, Yoshimura M, Kitaichi K, Hasegawa T, Saito K, Yamada Y, Seishima M, Sekikawa K, Kim HC, Nabeshima T.

J Neurosci. 2004 Mar 3;24(9):2212-25.

45.

Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.

Sugie M, Asakura E, Zhao YL, Torita S, Nadai M, Baba K, Kitaichi K, Takagi K, Takagi K, Hasegawa T.

Antimicrob Agents Chemother. 2004 Mar;48(3):809-14.

46.

Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats.

Asakura E, Nakayama H, Sugie M, Zhao YL, Nadai M, Kitaichi K, Shimizu A, Miyoshi M, Takagi K, Takagi K, Hasegawa T.

Eur J Pharmacol. 2004 Jan 26;484(2-3):333-9.

PMID:
14744620
47.

A sensitive colorimetric assay for polyamines in erythrocytes using oat seedling polyamine oxidase.

Takagi K, Tatsumi Y, Kitaichi K, Iwase M, Shibata E, Nakao M, Matsumoto T, Takagi K, Hasegawa T.

Clin Chim Acta. 2004 Feb;340(1-2):219-27.

PMID:
14734216
48.

Application of ultrafiltration method to measurement of catecholamines in plasma of human and rodents by high-performance liquid chromatography.

Ueyama J, Kitaichi K, Iwase M, Takagi K, Takagi K, Hasegawa T.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 5;798(1):35-41.

PMID:
14630356
49.

The expression of mRNA for calcitonin receptor-like receptor/receptor-activity modifying proteins in rat peritoneal mast cells.

Matsushima M, Kitaichi K, Tatsumi Y, Hasegawa T, Takagi K.

Eur J Pharmacol. 2003 Mar 19;464(2-3):111-4.

PMID:
12620502
50.

Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats.

Kitaichi K, Morishita Y, Doi Y, Ueyama J, Matsushima M, Zhao YL, Takagi K, Hasegawa T.

Eur J Pharmacol. 2003 Mar 7;464(1):39-48.

PMID:
12600693

Supplemental Content

Loading ...
Support Center